The upcoming gathering serves as a bridge between the clinical world of biotech and the families navigating cancer and rare diseases. Held in Philadelphia, the site where Emily Whitehead became the first pediatric patient successfully treated with CAR T-cell therapy, the event focuses on accelerating access to advanced treatments. Attendees will hear from a diverse group of "warrior" emcees, including Victoria Gray, a CRISPR advocate for sickle cell disease, and Marci McCue, who underwent CAR-T treatment for multiple sclerosis.
Emily Whitehead Foundation to Host 2026 Believe Ball in Philadelphia
Nine patients and advocates will share their experiences with life-saving medical breakthroughs at the Emily Whitehead Foundation’s 2026 Believe Ball on September 25. The event highlights the real-world impact of CAR T-cell therapy, CRISPR gene editing, and TIL therapy within the city where pediatric medical history was first made.
Beyond personal narratives, the evening will feature the presentation of the Bill Ludwig Pioneer Award and the Thomas G. Whitehead Beacon of Hope Award. The foundation will also distribute the annual Nicole Gularte Fight for Cures Grant to support ongoing research. With Novartis serving as the title sponsor, the event aims to translate individual survivor stories into a broader movement for patient advocacy, ensuring that groundbreaking therapies reach those who need them most.
Comments (0)
No comments yet. Be the first!